Elanco Animal Health Incorporated (ELAN) Return on equity 2016–2025
Elanco Animal Health Incorporated (ELAN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-3.5%FY2025 · since FY2016: -0.7% → -3.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.5% | -9.1 pp |
| FY2024 | 5.5% | +25.3 pp |
| FY2023 | -19.8% | -18.7 pp |
| FY2022 | -1.1% | +5.4 pp |
| FY2021 | -6.4% | +0.4 pp |
| FY2020 | -6.8% | -8.0 pp |
| FY2019 | 1.2% | -0.4 pp |
| FY2018 | 1.7% | +5.7 pp |
| FY2017 | -4.0% | -3.3 pp |
| FY2016 | -0.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ELAN financial trends
ELAN RevenueELAN Net incomeELAN Net marginELAN Gross profitELAN Gross marginELAN Operating incomeELAN Operating marginELAN Operating cash flowELAN Free cash flowELAN Capital expendituresELAN Stock buybacksELAN Dividends paidELAN Total assetsELAN Total liabilitiesELAN Shareholders’ equityELAN overview →